Charles Schwab Investment Management Inc Rhythm Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 433,866 shares of RYTM stock, worth $26.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
433,866
Previous 427,958
1.38%
Holding current value
$26.9 Million
Previous $17.6 Million
29.36%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding RYTM
# of Institutions
192Shares Held
67.3MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$448 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$418 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$397 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$377 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$241 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.46B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...